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On behalf of the editorial members, I am very pleased and 
honored to announce that Allergy, Asthma & Immunology Re-
search (AAIR) will be published bimonthly as of January, 2012. 
AAIR has been published quarterly since its first issue in Octo-
ber, 2009, under the auspices of the Korean Academy of Asth-
ma, Allergy and Clinical Immunology and the Korean Academy 
of Pediatric Allergy and Respiratory Disease. The previous 9 is-
sues of AAIR contained 97 articles, including timely clinical, ba-
sic science, and experimental research papers, and instructive 
case reports. As of October 2011, we have published 8 editori-
als, 32 reviews, 38 original articles, 17 case reports, and 2 brief 
communications. More than 30 world-famous scholars and 50 
domestic professors and researchers have contributed excel-
lent articles and distinguished papers to AAIR. More than 100 
reviewers have willingly acted as their critics, reviewing each 
article from the title to the end of the document. All of the 
members of the Korean Academy of Asthma, Allergy and Clini-
cal Immunology and the Korean Academy of Pediatric Allergy 
and Respiratory Disease would like to express our special ap-
preciation to the authors for their outstanding contributions to 
AAIR. As a result, AAIR was accepted for indexing in “Web of 
Science” , the largest, most comprehensive citation index avail-
able in 2011, making it the first Allergy and Asthma Journal in 
the Asia-Pacific region to be included. This reflects our goal of 
providing the most relevant and influential allergy, asthma, and 
immunology content to our community. After our entry into 
the Science Citation Index Expanded (SCIE), increasing num-
bers of manuscripts have been submitted to AAIR. This prompt-
ed us to increase the speed of our review system and the fre-
quency of issues published.
We are keen to develop AAIR as a leading journal for clinical 
and basic research on asthma, allergy, and clinical immunolo-
gy. To enhance its academic quality, we have invited world-
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class professors and researchers to join the AAIR Advisory and 
Editorial Boards. As the Editor-in-Chief, I heartily thank them 
for their continuing input to AAIR. On behalf of all of the Edi-
tors, I look forward to further excellent support and assistance 
from members of the Korean Academies. All of our members 
must strive to improve the quality and quantity of AAIR by sub-
mitting their clinical and research studies. We also ask our 
members to cite those articles already published in AAIR. Fi-
nally, I would like to express our deep appreciation to the asso-
ciate editors for their efforts and final decisions regarding pub-
lication of the manuscripts and our loyal, hard-working Editori-
al Office staff.
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